ChiCTR1800018812
结束
/
/
/
2018-10-11
/
/
肝硬化
硬化对腹腔镜胆囊切除术的临床研究：一项回顾性分析
硬化对腹腔镜胆囊切除术的临床研究：一项回顾性分析
本课题研究立足于国内外研究现状，查阅大量相关文献确定了研究方向，拟通过设计回顾性队列研究探讨肝硬化对腹腔镜胆囊切除术的影响，解决如何评估肝硬化患者行腹腔镜胆囊切除术的风险性及安全性的临床问题，为临床诊治提供理论依据
单臂
回顾性研究
N/A
N/A
No
/
70
/
2018-09-18
2018-12-31
/
1) patients are adults, and signed the informed consent form approved by the hospital ethics committee, which was in accordance with the medical ethics; 2) there was clear diagnosis of liver cirrhosis before the operation, which was determined according to clinical history, laboratory data, findings on images and the presence of varices on upper endoscopy or was confirmed by liver biopsy; 3) patients had symptomatic cholecystolithiasis who were able to undergo laparoscopic surgery. The diagnosis of cholecystolithiasis was confirmed by ultrasonography (US), computed tomography (CT) scan or magnetic resonance imaging (MRI), and there were obviously clinical symptoms (fever, abdominal distension, abdominal pain, vomiting and et al).；
请登录查看1) patients with decompensate liver disease, severe heart, brain or lung insufficiency before surgery; 2) patients with choledocholithiasis, pancreatitis, or other hepatobiliary diseases; 3) patients with a history of abdominal surgery; 4) patients who were unsuitable for laparoscopic surgery.；
请登录查看重庆医科大学附属第二医院
/
华东医药投资者关系2026-06-22
新药与伴随诊断网2026-06-22
兽药资讯2026-06-22
医药观澜2026-06-22
药智数据2026-06-22
赛德特生物2026-06-22
信达生物2026-06-22
药明康德2026-06-22
药渡2026-06-22
医药笔记2026-06-22
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
